Merck upgraded to Overweight at Morgan Stanley, target raised to $179
Merck (MRK) is upgraded to Overweight from Equal Weight at Morgan Stanley, which also raises its price target to $179 from $116.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
MRK upgraded to Overweight; price target raised to $179
Hammerstone MarketTalk upgrades MRK to Overweight and lifts its $179 price target from $116, while EW is listed as the prior designation.